期刊文献+

人宫颈癌基因RNA干扰真核表达载体的构建及其稳定转染胰腺癌细胞株的建立

Construction of eukaryotic expression vectors expressing siRNAs targeting the HCCR2 gene and their transfection into PANC1 cells
在线阅读 下载PDF
导出
摘要 目的:构建针对人宫颈癌基因2(HCCR2)有效靶点的RNA干扰真核表达载体,鉴定获得干扰质粒稳定转染的人胰腺癌PANC1细胞株.方法:设计并合成多个针对HCCR2基因的RNA干扰序列,并将其插入真核表达慢病毒载体pGCsi-H1/Hygro/NEGative,通过测序和与HCCR过表达载体共转染293T细胞后行Western blot检测,筛选出有效干扰质粒;通过脂质体转染法将该有效干扰质粒pGCsi-HCCR2稳定转染至人胰腺癌细胞株PANC1.抗生素G418筛选获得稳转细胞株;Western blot检测稳转细胞株中HCCR2蛋白表达水平.结果:HCCR2干扰载体和过表达载体共转染293T细胞后Western blot检测结果表明干扰质粒3具有最佳干扰效果,选其作为最终干扰质粒.将该质粒稳定转染至胰腺癌PANC1细胞后,Western blot检测显示,干扰组的PANC1细胞株与空载体组比较,HCCR2蛋白表达水平下调,表明获得HCCR2的RNA干扰质粒稳定转染的PANC1细胞株.结论:成功构建了HCCR2的RNA干扰真核表达载体及其稳定转染的人胰腺癌PANC1细胞株. AIM:To construct eukaryotic expression vectors expressing small interfering RNAs(siRNAs) targeting the human cervical cancer oncogene 2(HCCR2) gene and transfect them into human pancreatic cancer cell line PANC1 to obtain a cell line stably transfected with the HCCR2 siRNA plasmid.METHODS:Multiple siRNAs targeting the HCCR2 gene were designed,chemically synthesized,and cloned into the eukaryotic expression vector pGCsi-H1/Hygro/NEGative.The resulting recombinant vectors were identif ied by direct sequencing.After the recombinant pGCsi-HCCR plasmids were co-transfected with an HCCR eukaryotic expression vector into 293T cells,the protein expression of HCCR-2 was analyzed by Western blotting to identify the pGCsi-HCCR vector that had the highest gene knockdown efficiency.This recombinant vector was then transfected into PANC1 cells with LipofectamineTM 2000.G418-resistant clones were selected to obtain a stably transfected cell line.The expression of HCCR2 protein in stably transfected cell line was detected by Western blot.RESULTS:The pGCsi-HCCR-3 plasmid had the highest gene knockdown eff iciency and was used to transfect PANC1 cells.Western blotting analysis demonstrated that HCCR2 expression was signif icantly inhibited in PANC-1 cells sta-bly transfected with the pGCsi-HCCR-3 plasmid compared to cells transfected with the empty vector.CONCLUSION:Eukaryotic expression vectors expressing siRNAs targeting the HCCR2 gene were successfully constructed and a PANC-1 cell line stably transfected with the pGCsi-HCCR-3 plasmid was successfully established.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第14期1463-1468,共6页 World Chinese Journal of Digestology
基金 常州市社会发展科技计划基金资助项目 No.CS20102014~~
关键词 RNA干扰 人宫颈癌基因 PANC1细胞 稳定转染 RNA interference Human cervical cancer oncogene PANC1 cells Stable transfection
  • 相关文献

参考文献28

  • 1Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY, Kim IK, Namkoong SE, Kim JW. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene 2003; 22: 4679-4689.
  • 2张翼,徐泽宽,张国新,郝波,苗毅.组织芯片检测人宫颈癌癌基因和存活素在胰腺癌中的表达及临床意义[J].中华消化杂志,2008,28(2):129-130. 被引量:5
  • 3Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004; 198: 722-731.
  • 4Pliarchopoulou K, Pectasides D. Pancreatic cancer: current and future treatment strategies. Cancer Treat Rev 2009; 35: 431-436.
  • 5Hines OJ, Reber HA. Pancreatic neoplasms. Curr Opin Gastroenterol 2004; 20: 452-458.
  • 6Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S, Gollapudi S, Balakrishnan L, Dwivedi SB, Telikicherla D, Selvan LD, Goel R, Mathivanan S, Marimuthu A, Kashyap M, Vizza RF, Mayer RJ, Decaprio JA, Srivastava S, Hanash SM, Hruban RH, Pandey A. A compendium of potential biomarkers of pancreatic cancer. PLoS Med 2009; 6: e1000046.
  • 7Fry LC, M?nkemüller K, Malfertheiner P. Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg 2008; 393: 883-890.
  • 8Furukawa T. Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside. J Gastroenterol 2008; 43: 905-911.
  • 9Chung YJ, Kim JW. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer. Histol Histopathol 2005; 20: 999-1003.
  • 10Shin SM, Chung YJ, Oh ST, Jeon HM, Hwang LJ, Namkoong H, Kim HK, Cho GW, Hur SY, Kim TE, Lee YS, Park YG, Ko J, Kim JW. HCCR-1-interacting molecule & quot; deleted in polyposis 1& quot; plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology 2006; 130: 2074-2086.

二级参考文献73

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部